CHAPEL HILL, N.C., Feb. 25, 2026 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the publication of “Tecovirimat for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results